Jenny P. GluskerJudith KlinmanPilar SantistebanTim J. YenAlfred G. KnudsonKrisna C Duong-LyRoland DunbrackSuresh H. BasagoudanavarMichael Riis HansenDavid L. WiestJonathan ChernoffLuis Enrique Arias-RomeroLuis SigalHanqing LiuGordon ChanJoanna S SluskyZhigang TuCarolyn Y. FangHua MinL WiedemannPedro A. LazoPeter LopezVladislav KorobeynikovCarolyn J HeckmanMin FangBrett T SpearShawn P FahlBenjamin G BitlerIgor AstsaturovGlenn F RallAndrea FormanC CasliniFrank J ManionStephen J CapuzziAndrey ParkhitkoD. Callinice CAPO-CHICHIStephanie E WeissJayant James JayasundarVeda N GiriAttila A Seyhan
P108
P178
Carboxyamidotriazole in Treating Patients With Advanced Kidney CancerPhase 2 Trial of Maintenance Vigil for High Risk Stage IIIb-IV Ovarian CancerADAPT-BLADDER: Modern Immunotherpy in BCG-Relapsing Urothelial Carcinoma of the BladderVigil + Irinotecan and Temozolomide in Ewing's SarcomaIpilimumab With or Without High-Dose Recombinant Interferon Alfa-2b in Advanced MelanomaPhase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate CancerGenetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerGenetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationNext Generation Sequence Target-Directed Therapy in Treating Patients With CancerAddressing Sexual Concerns in Breast Cancer: Patient Intervention StudyA Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsA Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic CancerVaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate CancerAn Investigational Study Drug, Palbociclib (PD-0332991), Is Being Studied In Patients With Mantle Cell Lymphoma. Patients Must Have Received Prior Treatment(s) For Mantle Cell Lymphoma.Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial CancerStudy of Dasatinib (BMS-354825) in Patients With Advanced Estrogen/Progesterone Receptor-positive (ER+/PR+) or Her2/Neu-positive (Her2/Neu+)Breast CancerA Study Comparing Sequential Satraplatin & Erlotinib to Erlotinib in Unresectable Stage 3/4 Non-small-cell Lung Cancer (NSCLC)Study of Pralatrexate With Vitamin B12 and Folic Acid in Patients With Relapsed or Refractory Peripheral T-cell LymphomaRadiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent SurgeryA Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast CancerSafety and Efficacy of LCL161 in Patients With Solid TumorsRegorafenib in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal TumorClinical and Biological Predictors of Chemotherapy Toxicity in Older AdultsNivolumab (BMS-936558; MDX-1106) in Combination With Sunitinib, Pazopanib, or Ipilimumab in Subjects With Metastatic Renal Cell Carcinoma (RCC) (CheckMate 016)Study to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent TumorsA Study of Fractionated 90Y-hPAM4 Plus Gemcitabine in Pancreatic Cancer Patients Receiving at Least 2 Prior Therapies.An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid TumorsMorphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)Study of Positron Emission Tomography and Computed Tomography in Guiding Radiation Therapy in Patients With Stage III Non-small Cell Lung CancerPazopanib Hydrochloride in Treating Patients With Advanced AngiosarcomaEfficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & AbraxaneMinimally Invasive Groin Dissection for MelanomaStudy of Glembatumumab Vedotin (CDX-011) in Patients With Metastatic, gpNMB Over-Expressing, Triple Negative Breast CancerSargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced MelanomaA Study Of PF-06463922 An ALK/ROS1 Inhibitor In Patients With Advanced Non Small Cell Lung Cancer With Specific Molecular AlterationsNab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Cancer (the "Apact" Study)Paclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerEfficacy and Safety of Everolimus (RAD001) Compared to Placebo in Patients With Advanced Neuroendocrine TumorsStudy Evaluating Inotuzumab Ozogamicin (CMC-544) In Indolent Non-Hodgkins Lymphoma
P6153
Phase II Evaluation Of Paclitaxel And Cisplatin In Combination With Split Course Hyperfractionated RadiationGenetic Sequencing-Informed Targeted Therapy in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerGenetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing ChemoradiationNext Generation Sequence Target-Directed Therapy in Treating Patients With CancerAddressing Sexual Concerns in Breast Cancer: Patient Intervention StudyEducational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal CancerPrinted Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest CancerCounseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit SmokingStudy to Assess Safety and Tolerability of MLN8237, In Combination With Erlotinib to Treat Non-Small Cell Lung Cancer3-Dimensional Conformal Radiation Therapy or Intensity-Modulated Radiation Therapy in Treating Patients With Recurrent TumorsPazopanib Hydrochloride in Treating Patients With Advanced AngiosarcomaPaclitaxel and Ganetespib in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerPhysical Activity or Usual Care in Preventing Weight Gain in Women With Stage I or Stage II Breast Cancer Undergoing ChemotherapyBrigatinib in Relapsed or Refractory ALK-Positive Anaplastic Large Cell LymphomaCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Relapsed Non-Hodgkin's LymphomaGenetic and Environmental Risk Assessment for Colorectal Cancer in Healthy ParticipantsIrinotecan Plus Raltitrexed in Treating Patients With Refractory Solid TumorsIntensity-Modulated Radiation Therapy With Incorporated Boost and Capecitabine Before Surgery in Treating Patients With Locally Advanced Rectal CancerCelecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the BladderPaclitaxel, Topotecan, and Estramustine in Treating Patients With Metastatic Hormone-Refractory Prostate CancerIntensity-Modulated Radiation Therapy With or Without Decreased Radiation Dose to Erectile Tissue in Treating Patients With Stage II Prostate CancerAdjuvant Hypofractionated Intensity-Modulated Radiation Therapy With Incorporated Boost in Treating Patients With Early-Stage Breast CancerComputed Tomography (CT) Scans Using CT-On-Rails™ to Pinpoint the Location of the Tumor in Treating Patients With Prostate CancerTrastuzumab and Imatinib Mesylate in Treating Patients With Recurrent or Metastatic HER2/Neu-Expressing CancerVaccine Therapy Plus QS21 in Treating Patients With Advanced Pancreatic or Colorectal CancerCombination Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerFacilitating Follow-Up Adherence for Abnormal Pap SmearsRituximab and Combination Chemotherapy in Treating Patients With Previously Untreated High- or High-Intermediate-Risk Diffuse Large B-Cell LymphomaEvaluation of the Efficacy of National Cancer Institute's Facing Forward Booklet in the Cancer Community SettingCarboplatin, Paclitaxel, Cetuximab, and Erlotinib Hydrochloride in Treating Patients With Metastatic or Recurrent Head and Neck Squamous Cell CancerMychoice: Testing an Interactive mHealth ToolMolecular Monitoring With Circulating Tumor DNA and Nivolumab MaintenancePilot Study to Investigate The Diagnostic Yield and Utility of 22g and 19g Endobronchial Ultrasound Transbronchial Needle AspirateA Study of Pembrolizumab in Combination With Epacadostat in Women With Recurrent/Metastatic Endometrial CarcinomaPhase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLCPalliative and Oncology Care Intervention: Symptom COACH
P859
Q17576218-D4F0647B-2E6E-440C-97BC-9C707EB6A3C1Q18206807-32d60ff7-4abb-7b36-9e37-ea570d3882d8Q19803275-925D56AE-5B38-4978-B68D-41DFF6DF51FEQ30504251-36971B0D-2DD7-4B3C-A7C6-5ED7A3ACFFEAQ376149-BB7A6AE5-CBFB-40DB-A2BC-BBC81924ED82Q38319683-8455E3DB-37AC-43DE-9AD5-3E1C52A0F134Q41050584-AF87A8AE-50C0-4DA3-849D-A8269B108CEAQ41663999-D0D5F4DD-60AE-4D3D-AE65-628D669E720DQ41671536-334D7062-7E91-4B88-B628-732C0C5712EFQ41678244-A2F87E4F-0FF4-41D4-9976-82481F1ED295Q41836808-1FE30B4D-0037-4449-BE89-54A3E6EE3FCEQ42596338-4CEE89CF-B235-4E4E-8003-CADB802E5428Q42706292-933FB5CF-DA10-444D-8644-4ED1B44D4ED6Q43161853-021DB1A2-8D1A-4A5C-AFFF-BFE7E0820EF0Q45767771-A6385BC0-9153-4D43-849A-BD6CC4659EA6Q51035432-CB23B3E6-C5D1-47EE-A6A9-B968EAC1A3A9Q51058498-366E9C50-4973-49A2-998F-B23DFF52FD37Q53124445-3F7C0BEE-4AFA-4B0D-91F8-E59213983C00Q53585066-39865E6B-1ADF-4808-AF39-2851B05ECE09Q53974261-D62EF51E-55E4-4A64-AADD-A66802F65D56Q55112181-4019842F-3A28-4F7F-8F7D-95AE0523F6A7Q55112181-978B7288-63B6-4E21-A3D7-A3E954265C16Q55247052-42B67328-9010-4404-A061-78482F38710AQ56261370-C8DE8471-EBFF-455D-AA09-E2CCC6275386Q56418854-1A697394-618A-420B-A8AE-8A8E34A40593Q56441449-ADFA243F-13C3-4F10-A31E-D2CD3E312D22Q56441449-C257205F-A4A1-4A43-9E26-536B739D9422Q56441449-FA3D5942-3C87-42BB-920F-D39A7F6CD082Q56826448-4AAEE219-E14E-4458-A5DA-B3FEA698EF1AQ56894781-734141C8-AD56-425D-A5B3-A162F1BDDE43Q56956584-31D85830-166A-4298-9F34-ACCA611BF199Q56984385-A2A8873C-7728-4A19-A435-4983B22BC870Q56998456-912B2A72-F233-490A-AF11-98E39035B499Q57004432-FF761FF9-21D5-4F6A-A3FF-F083375F82CFQ57165348-9B615F37-77E7-483F-8A0B-B8C0DD3B9342Q57350709-9D661437-DF69-405B-9F4E-12D99785B212Q57425817-293DF7B6-6F0E-4C85-9314-6151A2A7A896Q57513770-5C7C3EA9-30E9-4D2D-A0B7-963ACD50DE1CQ57514452-7203653F-3012-46C3-8DF3-B718D31A3B30Q57614089-246AF5D0-9E25-4A5E-BFE8-85C2FF3F50F3
P108
Q58407313-301E4BBB-7BB5-4BCF-AC7D-61BDDD2D9A15Q58407640-E0FA808F-B4CC-420F-9434-DC6C11F44CECQ58846556-83009A82-B249-4CF4-AC54-D5F2108658DCQ58846874-D4A32B00-BB4F-4466-B392-5709A9125075Q61713089-1C23B721-6EF2-4DF2-A535-7E169C0FA747Q61864892-11D0FD70-D3E1-4451-9784-80D4A2EC4900Q61894207-5EE3DBC1-120B-4EEF-BD59-BEE9379090F7Q61894209-07A1BE3E-D7A6-4CBA-93FE-42A46F95F835Q61894210-0C8A539D-E9AF-43D0-8B32-FE1FF1AFCB74Q61902234-FF03E9FF-7F3E-49F4-BCC8-812EA0F91E5DQ61907592-BF28A700-824A-46D6-93F8-F5A55AD7F0E5Q61915256-F9E1216A-74E1-4A6C-BC9C-40D2EE0BA556Q61921070-513088EA-2E09-4701-ACB0-C94545BF778FQ61922010-712BE19D-2D5E-4412-8641-DE29CA08689CQ61922393-95A720B4-C058-4B39-9F7B-A2904A614F95Q61933172-479ACA72-B712-46CA-8700-0620D84F7B5BQ61933334-7046F384-8A42-4B90-8948-39F3419C382DQ61934419-F100BF00-A153-467D-BF5B-B0D023B124CDQ61936010-DECF42FC-4C71-485B-B751-CD2EC1FF8583Q61936011-7852EBFC-E1E6-4010-8414-9DA5E32C6DB2Q61936281-88F97DF1-30C1-4111-BE8A-4FE3344547EAQ61939001-B0969CB7-4A34-4914-941D-C63D0BCA1120Q61955485-83672878-33DB-42C2-99B0-9AAB9C7A677FQ61955488-D276B858-9F66-4046-B3E6-AD55033ACE25Q61955502-BB349F35-FB36-408F-9B70-42C4EC336A0CQ61955664-77F7F48E-FDFF-43A7-BCF0-678858D4B7A2Q61956174-4BBB495E-A38D-4ED6-AB3F-033215423BD1Q61956306-99933229-8146-4351-93F6-A87EEEE7C6ACQ61956730-042EA9E6-5044-492B-9E99-8EEB15D78C6FQ61956763-97E45D5A-A379-4400-888A-A9DCF871C093Q61957047-EEF13461-A764-4C00-9EB9-239E5EF970E6Q61957166-8EF63E00-468F-4FC1-8DC0-F56824A52628Q61957734-3061B685-0DD7-4F87-97BB-7B6343A377F4Q61969533-EABF8B6C-121D-4F87-B65D-82C17E91BE6CQ61970163-2887073E-F383-4BB0-A312-B8EFA931E083Q61975328-2CC7C2EA-2EB7-4B7D-934E-7DC7FFC8FE5FQ61975843-3310C5B4-8165-4E02-8E14-35F5990D76F3Q61975967-2B75D49C-F16D-44A5-BA7C-CFF74259E902Q61979296-C922799A-ACAD-4E5F-8E0C-CC24AF57A7CFQ61980794-88BD83E5-8CA0-4986-8A3C-CF57A3782F1D
P6153
description
Krankenhaus
@de
griya sakit
@jv
hospital d'Estaos Xuníos
@ast
hôpital
@fr
onderzoeksinstituut in Pennsylvania, Verenigde Staten van Amerika
@nl
research facility and hospital, United States
@en
rumah sakik
@min
rumah sakit di Amerika Serikat
@id
rumoh sakét
@ace
בית חולים בארצות הברית
@he
name
Fox Chase Cancer Center
@en
מרכז פוקס-צ'ייס לחקר הסרטן
@he
フォックス・チェイス・癌センター
@ja
福克斯·蔡斯癌症中心
@zh
type
label
Fox Chase Cancer Center
@en
מרכז פוקס-צ'ייס לחקר הסרטן
@he
フォックス・チェイス・癌センター
@ja
福克斯·蔡斯癌症中心
@zh
prefLabel
Fox Chase Cancer Center
@en
מרכז פוקס-צ'ייס לחקר הסרטן
@he
フォックス・チェイス・癌センター
@ja
福克斯·蔡斯癌症中心
@zh
P1278
P1566
P214
P244
P3153
P6366
P1278
549300XP3X8UTZSD0Q84
P131
P1417
topic/Fox-Chase-Cancer-Center
P1566
P213
0000 0001 2218 7820
P214
P2427
grid.249335.a
P244
P3153
P3417
Fox-Chase-Cancer-Center
P571
1904-01-01T00:00:00Z
P625
Point (-75.0902 40.0718)
P6366
1289437631